Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.58B |
| 2 |
Amphenol
APH
|
+$1.06B |
| 3 |
Eli Lilly
LLY
|
+$896M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$780M |
| 5 |
Snowflake
SNOW
|
+$615M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.24B |
| 2 |
NVIDIA
NVDA
|
+$1.89B |
| 3 |
Mercado Libre
MELI
|
+$1.5B |
| 4 |
Netflix
NFLX
|
+$1.32B |
| 5 |
Nike
NKE
|
+$826M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.63% |
| 2 | Communication Services | 15.64% |
| 3 | Consumer Discretionary | 12.05% |
| 4 | Healthcare | 9.65% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Antero Midstream
AM
$10.1B
| $18.3M | 0.01% |
1,026,140
-56,126
| -5% | -$1.01M |
|
352
Immunovant
IMVT
$8.25B
| $17.8M | 0.01% |
+700,464
| New | +$15.6M |
|
|
ABVX
353
Abivax
ABVX
$11.4B
| $17.2M | 0.01% |
+127,907
| New | +$14M |
|
|
SEI
354
Solaris Energy Infrastructure
SEI
$3.82B
| $17.2M | 0.01% |
374,417
-12,030
| -3% | -$582K |
|
355
Teledyne Technologies
TDY
$32B
| $16.7M | 0.01% |
32,757
-10,826
| -25% | -$5.7M |
|
356
Wolverine World Wide
WWW
$1.55B
| $16.4M | 0.01% |
903,801
-31,864
| -3% | -$644K |
|
357
Flutter Entertainment
FLUT
$16.4B
| $16.3M | 0.01% |
75,975
-34,704
| -31% | -$7.81M |
|
358
Ryan Specialty Holdings
RYAN
$11B
| $16.1M | 0.01% |
311,144
-392,433
| -56% | -$21.5M |
|
359
Steel Dynamics
STLD
$37.6B
| $15.8M | 0.01% |
+93,182
| New | +$14.8M |
|
360
Casey's General Stores
CASY
$30.9B
| $15.8M | 0.01% |
28,548
+1,251
| +5% | +$688K |
|
361
Coupang
CPNG
$29.2B
| $15.4M | 0.01% |
654,362
-22,861
| -3% | -$650K |
|
|
EFOR
362
Everforth Inc
EFOR
$1.32B
| $15.4M | 0.01% |
320,157
-272,890
| -46% | -$12.6M |
|
363
First Solar
FSLR
$26.9B
| $15.3M | 0.01% |
58,392
+3,016
| +5% | +$761K |
|
364
Baker Hughes
BKR
$61.1B
| $15.2M | 0.01% |
333,846
-3,997
| -1% | -$190K |
|
365
West Pharmaceutical
WST
$24.9B
| $15M | 0.01% |
54,593
+17,363
| +47% | +$4.75M |
|
366
Rio Tinto
RIO
$164B
| $15M | 0.01% |
187,269
+67,683
| +57% | +$4.87M |
|
367
Western Midstream Partners
WES
$19.3B
| $14.8M | 0.01% |
374,918
-20,798
| -5% | -$806K |
|
368
Compañía de Minas Buenaventura
BVN
$8.67B
| $14.7M | 0.01% |
+526,654
| New | +$13.1M |
|
|
CON
369
Concentra Group Holdings
CON
$4.36B
| $14.5M | 0.01% |
734,379
+42,012
| +6% | +$840K |
|
370
ConocoPhillips
COP
$141B
| $14.3M | 0.01% |
153,240
+10,779
| +8% | +$975K |
|
371
Palo Alto Networks
PANW
$297B
| $14.2M | 0.01% |
76,908
+23,990
| +45% | +$4.84M |
|
372
Valero Energy
VLO
$85.9B
| $14.1M | 0.01% |
86,660
-679
| -0.8% | -$115K |
|
|
XZO
373
Exzeo Group
XZO
$1.41B
| $14.1M | 0.01% |
+581,262
| New | +$11.1M |
|
374
Core Scientific
CORZ
$6.75B
| $14.1M | 0.01% |
+966,709
| New | +$16.9M |
|
375
PENN Entertainment
PENN
$2.71B
| $13.6M | 0.01% |
924,364
-20,996
| -2% | -$328K |
|
Similar funds
Jennison Associates's Q4 2025 Portfolio in Review
As of Q4 2025, Jennison Associates held 652 positions worth $167B, down 3% from $172B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates withdrew a net $7.12B in Q4 2025, closing 78 positions and reducing 263 holdings. Its most notable exit was Nike, an estimated $826M position sold in full.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Merck worth $585M.
- Jennison Associates's largest Q4 2025 buy was Merck: 5,559,488 shares worth $585M.
- Jennison Associates added most to Advanced Micro Devices in Q4 2025, an estimated $1.58B increase.
- Jennison Associates's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $2.24B.
- Jennison Associates fully exited Nike in Q4 2025, selling an estimated $826M.
- Jennison Associates's ten largest holdings make up 48% of its $167B portfolio in Q4 2025.
- Jennison Associates opened 92 new positions and closed 78 in Q4 2025.
- Jennison Associates's portfolio value fell 3% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.